Response of Differentiated Teratoma to Interferon
Author Information
Author(s): G.J.S. Rustin, S.B. Kaye, C.J. Williams, E.S. Newlands, K.D. Bagshawe, J.L. Toy
Primary Institution: Cancer Research Campaign Laboratories, Charing Cross Hospital
Hypothesis
Can lymphoblastoid interferon be effective in treating chemotherapy-resistant teratomas?
Conclusion
Lymphoblastoid interferon does not appear to be effective against anaplastic germ cell tumors but may help in treating unresectable differentiated teratomas.
Supporting Evidence
- Two patients with differentiated teratoma showed stabilization of disease after treatment.
- Eight patients experienced disease progression while on interferon.
- One patient had a mixed response lasting over 24 months.
Takeaway
This study looked at how a medicine called interferon worked on a type of tumor that didn't respond to regular cancer treatments. It found that while it didn't help some tumors, it might help others.
Methodology
A Phase 2 trial was conducted using intramuscular lymphoblastoid interferon in 10 patients with chemotherapy-resistant teratomas.
Potential Biases
Potential bias due to the small number of patients and lack of control group.
Limitations
The study had a small sample size and was not randomized.
Participant Demographics
9 men and 1 woman, aged 17 to 39.
Statistical Information
P-Value
0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website